(Total Views: 1063)
Posted On: 09/19/2017 5:28:45 AM
Post# of 30066
So frustrating to know that AMBS identified this compound before anyone else (JC discovered it) and amassed much IP around it but it's all for naught thus far.
My concern is that eventually the AMBS IP surrounding MANF will get sold off or transferred to some other investor/bio for pennies and then they will immediately start promoting all this impressive research surrounding the compound, begin some human trials, and get an immediate market cap of $500M-1B plus.
I sincerely hope I am wrong and continue to hold plenty of shares in the hope that I am wrong, but as more and more time passes that begins to look increasingly like the eventual outcome. If that were to happen, I think common shareholders would get nothing or next to nothing.
My concern is that eventually the AMBS IP surrounding MANF will get sold off or transferred to some other investor/bio for pennies and then they will immediately start promoting all this impressive research surrounding the compound, begin some human trials, and get an immediate market cap of $500M-1B plus.
I sincerely hope I am wrong and continue to hold plenty of shares in the hope that I am wrong, but as more and more time passes that begins to look increasingly like the eventual outcome. If that were to happen, I think common shareholders would get nothing or next to nothing.
(1)
(0)
